ORBIMED ADVISORS LLC Insider Trading $AMBI AMBIT BIOSCIENCES CORP
Get free email notifications about insider trading for ORBIMED ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ORBIMED ADVISORS LLC. ORBIMED ADVISORS LLC is Director in AMARIN CORP PLC\UK ($AMRN) and 10% Owner in AMBIT BIOSCIENCES CORP ($AMBI) and 10% Owner in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in INTERCEPT PHARMACEUTICALS INC ($ICPT) and Director in Anthera Pharmaceuticals Inc ($ANTH) and 10% Owner in COMPLETE GENOMICS INC ($GNOM) and 10% Owner in Pacira Pharmaceuticals, Inc. ($PCRX) and 10% Owner in Relypsa Inc ($RLYP) and 10% Owner in Mirati Therapeutics, Inc. ($MYG).
ORBIMED ADVISORS LLC in AMBIT BIOSCIENCES CORP
Trading Symbol: AMBIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ORBIMED ADVISORS LLC: 10% Owner
Holdings: 14,067 shares
Latest Transaction: May 24 2013
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of ORBIMED ADVISORS LLC in AMBIT BIOSCIENCES CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRN, AMBI, ANTH, GNOM, ICPT, MYG, PCRX, RLYP
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.99 | 120 | 839 | 14,067 | 13.9 K to 14.1 K (+0.86 %) |
May 24 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.99 | 12,380 | 86,528 | 1,476,702 | 1.5 M to 1.5 M (+0.85 %) |
May 24 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.86 | 200 | 1,372 | 13,947 | 13.7 K to 13.9 K (+1.45 %) |
May 24 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.86 | 21,100 | 144,767 | 1,464,322 | 1.4 M to 1.5 M (+1.46 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 18,795 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 1,973,439 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 50,256 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 5,276,702 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 83,959 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 8,815,565 | 0 | 0 | |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.90 | 80 | 552 | 13,747 | 13.7 K to 13.7 K (+0.59 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.90 | 8,020 | 55,314 | 1,443,222 | 1.4 M to 1.4 M (+0.56 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.00 | 590 | 4,720 | 13,667 | 13.1 K to 13.7 K (+4.51 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.00 | 61,910 | 495,280 | 1,435,202 | 1.4 M to 1.4 M (+4.51 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.00 | 5,653 | 45,224 | 13,077 | 7.4 K to 13.1 K (+76.14 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.00 | 593,618 | 4,748,944 | 1,373,292 | 779.7 K to 1.4 M (+76.14 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 1,730 | 0 | 7,424 | 5.7 K to 7.4 K (+30.38 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 181,689 | 0 | 779,674 | 598 K to 779.7 K (+30.38 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,094 | 0 | 5,694 | 3.6 K to 5.7 K (+58.17 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 219,863 | 0 | 597,985 | 378.1 K to 598 K (+58.15 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 3,498 | 0 | 3,600 | 102 to 3.6 K (+3,429.41 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 367,315 | 0 | 378,122 | 10.8 K to 378.1 K (+3,398.86 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.78 | 100 | 678 | 102 | 2 to 102 (+5,000.00 %) |
May 22 2013 | AMBI | AMBIT BIOSCIENCES ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 6.78 | 10,500 | 71,162 | 10,807 | 307 to 10.8 K (+3,420.20 %) |
Page: 1